Real-World Experience with TRK Inhibitors in Patients with Lung and Colon Cancers

Ezra Cohen, MD, FRCPSC, FASCO; Mary Jo Fidler, MD; Arturo Loaiza-Bonilla, MD, MSEd, FACP

Video Categories: NTRK Gene Fusions

Dr Mary Fidler of Rush University Medical Center, Chicago, IL, and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, describe their practical experiences with TRK inhibitors in patients with lung cancer and colorectal cancer.

July 29, 2015

Introducing New Agents into the Standard of Care

Dr. S. Yosuf Zafar questions how to incorporate new agents into the standard of cancer care as many of these agents are both expensive and only useful for a small segment of patients.

January 20, 2016

Defining Cancer Stem Cells

Dr Gerson provides an overview of cancer stem cells.